O'Brien James Michael 4
4 · ENZO BIOCHEM INC · Filed Aug 2, 2018
Insider Transaction Report
Form 4
O'Brien James Michael
SVP of Finance
Transactions
- Award
Stock Option (to acquire common stock)
2018-07-31+35,000→ 23,666 totalExercise: $4.42From: 2019-08-01Exp: 2023-07-31→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted 35,000 stock options. The options have a five-year term and shall vest in three equal annual tranches, beginning August 1, 2019.
- [F2]Does not include 4,000 Performance Stock Units granted to the Reporting Person on July 31, 2018, which will vest, if at all, based upon (i) achievement of average revenue growth and adjusted EBITDA growth goals on July 31, 2021, and (ii) the continued service of the Reporting Person through July 31, 2021.